|Day's Range||64.917 - 65.200|
|52 Week Range||55.100 - 66.800|
|PE Ratio (TTM)||41.46|
|Earnings Date||Jul 28, 2017|
|Dividend & Yield||1.88 (2.94%)|
|1y Target Est||N/A|
UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).
Merck & CO, Inc. (MRK) announced that it has bought exclusive worldwide license from Teijin Pharma for the development, manufacture and commercialization of an investigational preclinical anti-tau antibody.
The Zacks Analyst Blog Highlights: Merck, 3M, United Technologies, Ford Motor and Humana